HμREL
About:
HμREL, a bioanalytic tools firm, researches, develops and commercializes products and services based on 3D cell-based tissue constructs.
Website: http://www.hurelcorp.com
Twitter/X: hurel_corp
Top Investors: Spring Mountain Capital
Description:
HμREL® Corporation is an early-stage bioanalytic tools company with operations based in Kenilworth and New Brunswick, New Jersey, USA. Robert Freedman serves as Chief Executive Officer. Martin Yarmush is the Company’s Chief Scientific Adviser.
Total Funding Amount:
$9.2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
North Brunswick, New Jersey, United States
Founded Date:
2005-01-01
Contact Email:
hello(AT)hurelcorp.com
Founders:
Robert M. Freedman
Number of Employees:
11-50
Last Funding Date:
2013-04-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai